1167
CLINICO-MORPHOLOGICAL CORRELATION OF RESECTED PANCREATIC DUCTAL ADENOCARCINOMA AFTER NEOADJUVANT TREATMENT
Date
May 9, 2023
Explore related products in the following collection:
Tracks
Related Products
PANCREATIC CYSTIC NEOPLASMS: STILL HIGH RATES OF PREOPERATIVE MISDIAGNOSIS IN THE GUIDELINES AND EUS ERA
LUNCH AND TRAINEE JEOPARDY! 12:00 PM - 1:00 PM LEADERSHIP FORUM, NETWORKING SESSION AND ROUNDTABLES 4:00 PM - 5:30 PM KEYNOTE ADDRESS: FUTURE SCENARIO PLANNING TO PREDICT THE FUTURE OF SURGERY 4:00 PM - 4:30 PM
EXTENDING QUALITY IMPROVEMENT FOR PANCREATODUODENECTOMY WITHIN THE HIGH-VOLUME SETTING: THE EXPERIENCE FACTOR
INTRODUCTION. Microvascular invasion (MVI) is the main risk factor for overall mortality and recurrence after surgery for hepatocellular carcinoma (HCC). Its diagnosis can be made only postoperatively on the histological specimen…
DISSECTING THE ROLE OF NODAL METASTASES LOCATION IN PANCREATODUODENECTOMY AFTER NEOADJUVANT TREATMENT FOR CANCER: RESULTS FROM A PROSPECTIVE LYMPHADENECTOMY PROTOCOL
IMPORTANCE: Guidelines recommend surgical exploration in selected patients with locally advanced pancreatic cancer (LAPC) following induction chemotherapy…
EXTENDING QUALITY IMPROVEMENT FOR PANCREATODUODENECTOMY WITHIN THE HIGH-VOLUME SETTING: THE EXPERIENCE FACTOR
LUNCH AND TRAINEE JEOPARDY! 12:00 PM - 1:00 PM LEADERSHIP FORUM, NETWORKING SESSION AND ROUNDTABLES 4:00 PM - 5:30 PM KEYNOTE ADDRESS: FUTURE SCENARIO PLANNING TO PREDICT THE FUTURE OF SURGERY 4:00 PM - 4:30 PM